World Health Day advocates that everyone should have access to quality healthcare services when and where they need them without facing financial hardship. Unfortunately, many people still lack access to essential and life-saving health services, especially those living in rural areas, which can result in preventable illnesses, disabilities and even death.
FAME continues to work towards health equity and improved healthcare access to underserved communities in rural Tanzania. FAME believes everyone should be able to achieve good health and well-being regardless of where they live or their social and economic status.
Today we share a story about the lack of access to healthcare due to financial difficulties. Anita* is a 35-year-old single mother of one who is suffering from Multiple Sclerosis (MS). MS is a chronic autoimmune disease that affects the central nervous system. Unfortunately, MS is a relatively rare condition in Tanzania and progress has been very limited regarding the diagnosis and treatment of MS in Tanzania (MSIF).
After diagnosis, Anita could not afford the MS medication due to its unavailability locally and high prices in neighboring countries. Access to affordable MS medications is not just an issue in Tanzania but also a critical issue in the United States (NMSS). The cost of MS drugs has doubled in the last seven years, despite introducing a generic form of the widely used drug. Access to treatments is difficult in many countries and often impossible in others.
Anita’s Story
Anita* lives in Arusha with her 6-year-old son. She works in a rehabilitation center for disabled children as an occupational therapist. Her first symptom was muscle weakness and stiffness, making it difficult to move around or perform everyday tasks. Then came the deliberating extreme fatigue. She also had difficulty with coordination and balance, leading to falls and challenges performing activities that require balance.
Dr. Michael Rubenstein has been coming to FAME for the past thirteen years with neurology residents and fellows from the University of Pennsylvania and Children’s Hospital of Philadelphia. In partnership with FAME, they provide neurological care for those living in our catchment area both at FAME and in outreach clinics where they venture into the villages.
For a year after diagnosis, Anita did not take any medicine. It just wasn't attainable. In 2023, after sourcing for approval from the Tanzania Ministry of Health, Dr. Rubenstein and his residents brought her MS medicine from the US, which had been donated. They brought enough medication to last her for more than six months, with plans to bring additional medication when they return in September.
Anita says that she has suffered a lot of stigma surrounding her disease, including from her own family.
Neurologist Resident, Dr. Wells Seldes Andres, teaches Anita how to inject her medicine. He assures her that the medicine has no significant side effects except maybe a sore arm. He also tells her that MS doesn't change life expectancy with proper treatment.
Dr. Michael Rubenstein
“Multiple sclerosis is a disease that is thought to be very uncommon in sub-Saharan Africa. However, recent data suggest its incidence is increasing here just as in other parts of the world.
There are several reasons why it is uncommon here, including environmental and hereditary reasons, the lack of specialists (neurologists) and the lack of technology used to make the diagnosis that has only recently existed in this region of Africa. Unfortunately, due to the belief that it is uncommon here, there are also very few studies looking at MS in East Africa, which will hopefully change in the coming years as we learn more.
In the thirteen years that I have been coming to Northern Tanzania, there have been a number of cases in which we were concerned about MS. Still, due to the very limited resources (monetary and technological), we have been unable to pursue the diagnosis fully.
Anita is one of the more fortunate patients who were not only able to have the appropriate study done but, more importantly, was able to come to our clinic where we confirmed her diagnosis and were able to begin treatment against all odds as there are no medications in Tanzania that are specifically designed for MS.”
*The patient’s name has been changed to protect their privacy and permission was secured to share her story.